Clinical Trials on Fibrotic Lung Disease
Total 381989 results
-
Boehringer IngelheimNo longer availableIdiopathic Pulmonary FibrosisBrazil
-
Asahi Kasei Pharma CorporationCompletedIdiopathic Pulmonary FibrosisJapan
-
GlaxoSmithKlineTerminatedIdiopathic Pulmonary FibrosisUnited Kingdom
-
University of AarhusEurostarsUnknownFeasibility & Effect of a Tele-rehabilitation Program in Idiopathic Pulmonary Fibrosis (IPF) (3-IPF)Idiopathic Pulmonary FibrosisDenmark
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisCanada, United States, Netherlands, France, Italy, Germany
-
Royal Brompton & Harefield NHS Foundation TrustNational Institute for Health Research, United KingdomCompletedIdiopathic Pulmonary FibrosisUnited Kingdom
-
Royal Brompton & Harefield NHS Foundation TrustNational Institute for Health Research, United KingdomCompleted
-
Brigham and Women's HospitalNational Heart, Lung, and Blood Institute (NHLBI); University of Chicago; Columbia... and other collaboratorsCompletedIdiopathic Pulmonary FibrosisUnited States
-
Gilead SciencesTerminatedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Israel, Australia, Italy, Canada, United Kingdom, Switzerland, Germany, Poland, Czechia, Belgium, France
-
Genentech, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisGermany, United Kingdom, Ireland, France, Austria, Denmark, Finland, Italy, Norway, Sweden
-
Genentech, Inc.CompletedIdiopathic Pulmonary Fibrosis | Pulmonary FibrosisUnited States
-
Genentech, Inc.CompletedIdiopathic Pulmonary FibrosisUnited States
-
Hoffmann-La RocheInterMune Deutschland GmbHCompletedIdiopathic Pulmonary FibrosisGermany
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Australia, Canada, Czech Republic, Germany, Ireland, Israel, Italy, Switzerland
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, France, Spain, Korea, Republic of, Canada, United Kingdom, Australia, Belgium, Netherlands, Japan, Germany, Czech Republic, Italy, Switzerland, Austria, Croatia, Ireland, Israel, Serbia
-
Genentech, Inc.Approved for marketingIdiopathic Pulmonary Fibrosis
-
Genzyme, a Sanofi CompanyCompletedIdiopathic Pulmonary FibrosisUnited States, Belgium
-
US Department of Veterans AffairsCompletedIdiopathic Pulmonary FibrosisUnited States
-
Duke UniversityNational Heart, Lung, and Blood Institute (NHLBI); Duke Clinical Research InstituteTerminatedIdiopathic Pulmonary FibrosisUnited States
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, Israel, Spain, Australia, France, Canada, Turkey, Germany, Italy, South Africa, Slovenia, Sweden
-
ImmuneWorksCompletedIdiopathic Pulmonary FibrosisUnited States
-
Institut National de la Santé Et de la Recherche...CompletedIdiopathic Pulmonary Fibrosis
-
ActelionCompletedIdiopathic Pulmonary FibrosisUnited States, United Kingdom, Switzerland, Israel, Canada, France, Germany, Italy
-
Rabin Medical CenterUnknownIdiopathic Pulmonary FibrosisIsrael
-
InterMuneCompletedIdiopathic Pulmonary FibrosisUnited States
-
University of MichiganCompletedCystic Fibrosis | Lung Transplant
-
Federal Research Clinical Center of Federal Medical...CompletedIdiopathic Pulmonary Fibrosis | Interstitial Lung Disease | Idiopathic Interstitial PneumoniaRussian Federation
-
Jianwu DaiSouthwest Hospital, ChinaCompletedPost-radiotherapy Pulmonary FibrosisChina
-
Assiut UniversityUnknownInterstitial Lung Disease | Skeletal Muscle Dysfunction
-
Yonsei UniversityRecruitingIdiopathic Pulmonary Fibrosis With Acute ExacerbationKorea, Republic of
-
Erasmus Medical CenterRecruitingPulmonary FibrosisUnited Kingdom, Germany, Netherlands, France
-
Massachusetts General HospitalNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPulmonary Fibrosis | Lung CancerUnited States
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceRecruitingIdiopathic Pulmonary Fibrosis | Pulmonary Disease | Pulmonary MedicineFrance
-
University of Modena and Reggio EmiliaRecruitingIdiopathic Pulmonary Fibrosis | Mechanical Ventilation Pressure HighItaly
-
Istanbul Medipol University HospitalCompletedIdiopathic Pulmonary FibrosisTurkey
-
Cedars-Sinai Medical CenterGenentech, Inc.Recruiting
-
Blade TherapeuticsNot yet recruitingRESPIRARE - Efficacy and Safety of Cudetaxestat in Patients With Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary Fibrosis
-
University Hospital, ToursInstitut National de la Santé Et de la Recherche Médicale, FranceRecruitingIdiopathic Pulmonary FibrosisFrance
-
Novartis PharmaceuticalsTerminatedIdiopathic Pulmonary FibrosisUnited States, Germany, Italy, Canada, Ireland, United Kingdom
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisGreece
-
Assistance Publique - Hôpitaux de ParisCompletedIdiopathic Pulmonary FibrosisFrance
-
Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States, Netherlands, Italy, Germany, Switzerland, Czechia, Spain
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Belgium, Australia, United Kingdom, Canada, China, Germany, Japan, Turkey, France, Ireland, Italy, Israel, Netherlands, Portugal, Greece, India, Czechia, Chile, Finland, Mexico, Russian Federation
-
Belgian Thoracic SocietyBoehringer Ingelheim; Roche Farma, S.ACompletedIdiopathic Pulmonary FibrosisBelgium, Luxembourg
-
Institut d'Investigació Biomèdica de BellvitgeCompleted
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States
-
University Hospital, ToursCompletedIdiopathic Pulmonary FibrosisFrance
-
Steward St. Elizabeth's Medical Center of Boston...Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States
-
The University of Hong KongQueen Mary Hospital, Hong KongTerminatedIdiopathic Pulmonary FibrosisHong Kong